|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/08 | |
| C07B 59/00 | |||
| A61K 31/195 | |||
| A61K 31/4709 | |||
| A61K 31/485 | |||
| A61P 25/16 | |||
| A61P 29/00 | |||
| A61P 25/08 |
| (11) | Number of the document | 3248978 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17179704.6 |
| Date of filing the European patent application | 2009-09-18 | |
| (97) | Date of publication of the European application | 2017-11-29 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-07 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 98511 P | 2008-09-19 | US |
| (72) |
Graham, Philip B., US
Silverman, I. Robert, US
|
| (73) |
Concert Pharmaceuticals Inc.,
99 Hayden Avenue, Suite 100, Lexington, MA 02421,
US
|
| (54) | DEUTERATED MORPHINAN COMPOUNDS |
| DEUTERATED MORPHINAN COMPOUNDS |